HC Andersen Capital Events 15/02: Meet the top management in ExpreS2ion Biotechnologies
HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.ExpreS2ion Biotechnologies - Presentation of year-end report 2022On the 9th of February, ExpreS2ion Biotechnologies released its Q4 2022 and full-year 2022 results. In Q4 2022, the company's operating income fell 64% to SEK 1.59m, and the loss from the period amounted to SEK -48.5m in the quarter (SEK -14.3m in Q4 2021). The operating income is as expected, as the focus is shifted from its legacy CRO business to developing pipeline